Compare Siemens Healthineers AG with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
EUR 38,634 Million ()
17.00
NA
2.92%
0.81
12.84%
2.12
Revenue and Profits:
Net Sales:
5,764 Million
(Quarterly Results - Jun 2026)
Net Profit:
676 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
17.93%
0%
17.93%
6 Months
-1.27%
0%
-1.27%
1 Year
-13.73%
0%
-13.73%
2 Years
-21.2%
0%
-21.2%
3 Years
-16.11%
0%
-16.11%
4 Years
-24.22%
0%
-24.22%
5 Years
-32.23%
0%
-32.23%
Siemens Healthineers AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.96%
EBIT Growth (5y)
7.28%
EBIT to Interest (avg)
13.12
Debt to EBITDA (avg)
3.17
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.62
Tax Ratio
22.87%
Dividend Payout Ratio
52.23%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
9.54%
ROE (avg)
11.15%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.14
EV to EBIT
15.77
EV to EBITDA
11.46
EV to Capital Employed
1.66
EV to Sales
2.25
PEG Ratio
NA
Dividend Yield
2.90%
ROCE (Latest)
10.55%
ROE (Latest)
12.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 3 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
5,764.00
5,662.00
1.80%
Operating Profit (PBDIT) excl Other Income
1,327.00
1,242.00
6.84%
Interest
103.00
104.00
-0.96%
Exceptional Items
-68.00
-131.00
48.09%
Consolidate Net Profit
676.00
556.00
21.58%
Operating Profit Margin (Excl OI)
177.30%
154.00%
2.33%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 1.80% vs 4.41% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 21.58% vs 17.80% in Jun 2025
Annual Results Snapshot (Consolidated) - Sep'25
Sep'25
Sep'24
Change(%)
Net Sales
23,375.00
22,363.00
4.53%
Operating Profit (PBDIT) excl Other Income
4,731.00
4,523.00
4.60%
Interest
425.00
476.00
-10.71%
Exceptional Items
-250.00
-431.00
42.00%
Consolidate Net Profit
2,168.00
1,959.00
10.67%
Operating Profit Margin (Excl OI)
147.00%
147.60%
-0.06%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2025 is 4.53% vs 3.15% in Sep 2024
Consolidated Net Profit
YoY Growth in year ended Sep 2025 is 10.67% vs 28.46% in Sep 2024
About Siemens Healthineers AG 
Siemens Healthineers AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






